Singular Genomics Systems PE Ratio 2020-2023 | OMIC
Current and historical p/e ratio for Singular Genomics Systems (OMIC) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Singular Genomics Systems PE ratio as of May 10, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Singular Genomics Systems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-10 | 0.41 | 0.00 | |
| 2023-12-31 | 0.46 | $-1.31 | 0.00 |
| 2023-09-30 | 0.38 | $-1.28 | 0.00 |
| 2023-06-30 | 0.83 | $-1.30 | 0.00 |
| 2023-03-31 | 1.21 | $-1.29 | 0.00 |
| 2022-12-31 | 2.01 | $-1.27 | 0.00 |
| 2022-09-30 | 2.50 | $-1.25 | 0.00 |
| 2022-06-30 | 3.82 | $-1.17 | 0.00 |
| 2022-03-31 | 6.31 | $-2.01 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.031B | $0.003B |
| Singular Genomics Systems Inc. is a life science technology company. It focused on delivering genomic technologies for the advancement of science and medicine. Singular Genomics Systems Inc. is based in LA JOLLA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.315B | 15.72 |
| Cencora (COR) | United States | $44.797B | 17.47 |
| ICON (ICLR) | Ireland | $26.018B | 24.56 |
| DiDi Global (DIDIY) | China | $23.816B | 0.00 |
| Avantor (AVTR) | United States | $16.839B | 24.79 |
| CochLear (CHEOY) | Australia | $13.827B | 0.00 |
| Viatris (VTRS) | United States | $13.288B | 3.97 |
| Revvity (RVTY) | United States | $12.932B | 22.68 |
| Natera (NTRA) | United States | $12.715B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.253B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.089B | 39.78 |
| Charles River Laboratories (CRL) | United States | $11.751B | 22.50 |
| Solventum (SOLV) | United States | $10.996B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.479B | 0.00 |
| HealthEquity (HQY) | United States | $6.635B | 49.57 |
| Bausch + Lomb (BLCO) | Canada | $5.417B | 21.70 |
| Organon (OGN) | United States | $5.251B | 4.98 |
| Doximity (DOCS) | United States | $4.360B | 32.46 |
| PACS (PACS) | United States | $3.734B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.379B | 30.92 |
| Sotera Health (SHC) | United States | $3.125B | 15.33 |
| Life Times (LTH) | United States | $2.905B | 30.44 |
| Progyny (PGNY) | United States | $2.646B | 45.13 |
| GoodRx Holdings (GDRX) | United States | $2.607B | 94.29 |
| Premier (PINC) | United States | $2.336B | 8.74 |
| Agilon Health (AGL) | United States | $2.134B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.073B | 8.24 |
| Teladoc Health (TDOC) | United States | $2.027B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.926B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.772B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.540B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.306B | 0.00 |
| Embecta (EMBC) | United States | $0.821B | 5.58 |
| CareDx (CDNA) | United States | $0.772B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.701B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.692B | 7.34 |
| InnovAge Holding (INNV) | United States | $0.555B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.542B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.537B | 0.00 |
| MultiPlan (MPLN) | United States | $0.455B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.447B | 0.00 |
| Enhabit (EHAB) | United States | $0.418B | 41.70 |
| LifeMD (LFMD) | United States | $0.394B | 0.00 |
| ModivCare (MODV) | United States | $0.373B | 6.98 |
| Beauty Health (SKIN) | United States | $0.338B | 0.00 |
| DocGo (DCGO) | United States | $0.315B | 16.78 |
| Sera Prognostics (SERA) | United States | $0.300B | 0.00 |
| Sharecare (SHCR) | United States | $0.280B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.181B | 0.00 |
| So-Young (SY) | China | $0.131B | 44.00 |
| Oncology Institute (TOI) | United States | $0.069B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 6.84 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.031B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |